Answer
Glofitamab (Columvi) is contraindicated in people with hypersensitivity to glofitamab, obinutuzumab, or any Columvi excipient listed in section 6.1 of its prescribing information.
Sources for this answer
- Columvi 2.5 mg, 10 mg concentrate for solution for infusionRoche Products Limited · emc · SmPC §4.3 Contraindications · Version 6Document updated
Sources checked